StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 13, 2026, 11:11 PM

Erasca Prices Upsized Public Offering of 31.4M Shares at $17.50

AI Summary

Erasca, Inc. announced the pricing of an upsized public offering of 31,428,572 shares of its common stock at $17.50 per share. The offering is expected to generate gross proceeds of approximately $550.0 million for the company. Erasca has also granted underwriters an option to purchase up to an additional 4,714,285 shares. The net proceeds from this offering will be used to fund research and development of its product candidates and for general corporate purposes.

Key Highlights

  • Erasca priced an upsized public offering of 31,428,572 shares of common stock.
  • Shares are being sold at a price of $17.50 per share.
  • Gross proceeds are expected to be approximately $550.0 million.
  • Underwriters have a 30-day option to purchase up to an additional 4,714,285 shares.
  • Offering is expected to close on July 15, 2026.
  • Net proceeds will fund R&D of product candidates and general corporate purposes.
  • J.P. Morgan, Morgan Stanley, Jefferies, and Evercore ISI are joint book-running managers.